MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Frontal atrophy in progressive supranuclear palsy[PSP] -an universal feature along with midbrain atrophy?

A. Panwar, A. Prasad, S. Anand (SAS Nagar, India)

Meeting: 2024 International Congress

Abstract Number: 986

Keywords: Magnetic resonance imaging(MRI), Prefrontal cortex(PFC), Progressive supranuclear palsy(PSP)

Category: Neuroimaging (Non-PD)

Objective: To see if frontal atrophy is a frequent radiologic  feature of PSP on MRI imaging .

Background: Progressive supranuclear palsy[PSP]  is a  taupathy  that causes problems with walking, balance , frequent falls, behaviour issues, difficulty in swallowing and vertical eye movements. Due to common clinical features, it is often confused and misdiagnosed as Parkinson’s disease, especially in initial stages of the disease. PSP is most commonly diagnosed using a combination of clinical signs and  MRI(Magnetic Resonanace Imaging)

Method: We evaluated 12 patients of PSP on MRI; MRI scans were done on 1.5 Tesla and 3 Tesla MRI at two separate centres. High resolution 3D T1 weighted volumetric spoiled gradient echo images acquired in sagittal, axial and coronal planes were used. MRPI(Magnetic Resonance Parkinsonism Index) was calculated using equation: MRPI = (P/M) x (MCP/SCP) where P and M represent surface area of pons and midbrain and MCP and SCP represent width of middle cerebellar peduncle and superior cerebellar peduncle . MRPI values >13.55 suggest a diagnosis of PSP [Fig 1 shows Saggital sections and Fig 2 shows coronal sections  of MRI images of patients]. Diagnosis of PSP was made using  clinical and MRI criteria. In addition ,frontal lobe atrophy was qualitatively evaluated in these patients by two experienced neuroradiologists, each with >10 years of experience.

Results: 11 patients had MRPI values >13.55 , one patient’s value was 12.20 [91.66% patients had MRPI abnormality ] . Moderate to severe frontal atrophy was found on MRI in all 12 patients with PSP[100% patients had frontal atrophy].

Conclusion: Our study confirms the association between PSP and frontal atrophy [Ref 1] and emphasizes that in cases where brainstem measurements are inconclusive in differentiating PSP from Parkinson’s disease, frontal lobe atrophy can serve as a sensitive marker to differentiate the two.  Further research is needed to evaluate the usefulness of frontal atrophy in early diagnosis of PSP in addition to midbrain atrophy and to see if it predates midbrain atrophy.

Fig 1 - Panel showing MRI,Saggital Sequence.

Fig 1 – Panel showing MRI,Saggital Sequence.

Fig 2 - Panel showing MRI,Coronal  Sequence

Fig 2 – Panel showing MRI,Coronal Sequence

References: 1. Rowe JB, Holland N, Rittman T. Progressive supranuclear palsy: diagnosis and management. Pract Neurol. 2021 Oct;21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2. PMID: 34215700; PMCID: PMC8461411.

To cite this abstract in AMA style:

A. Panwar, A. Prasad, S. Anand. Frontal atrophy in progressive supranuclear palsy[PSP] -an universal feature along with midbrain atrophy? [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/frontal-atrophy-in-progressive-supranuclear-palsypsp-an-universal-feature-along-with-midbrain-atrophy/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/frontal-atrophy-in-progressive-supranuclear-palsypsp-an-universal-feature-along-with-midbrain-atrophy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley